FAROTTI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 1.175
AS - Asia 933
EU - Europa 585
SA - Sud America 134
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 20
OC - Oceania 1
Totale 2.917
Nazione #
US - Stati Uniti d'America 1.132
SG - Singapore 441
IE - Irlanda 141
VN - Vietnam 134
CN - Cina 126
BR - Brasile 101
IT - Italia 94
RU - Federazione Russa 93
HK - Hong Kong 92
DE - Germania 53
FR - Francia 53
BD - Bangladesh 37
FI - Finlandia 25
RO - Romania 23
GB - Regno Unito 20
IN - India 18
CA - Canada 17
IQ - Iraq 16
SE - Svezia 16
MX - Messico 15
JP - Giappone 14
UA - Ucraina 14
AR - Argentina 12
PL - Polonia 12
AT - Austria 11
TR - Turchia 11
CO - Colombia 7
NL - Olanda 7
ES - Italia 6
KR - Corea 6
BE - Belgio 5
DZ - Algeria 5
ID - Indonesia 5
PK - Pakistan 5
MA - Marocco 4
SA - Arabia Saudita 4
VE - Venezuela 4
ZA - Sudafrica 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
JM - Giamaica 3
LY - Libia 3
NP - Nepal 3
UZ - Uzbekistan 3
AL - Albania 2
AM - Armenia 2
CH - Svizzera 2
IL - Israele 2
JO - Giordania 2
MY - Malesia 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BF - Burkina Faso 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
RW - Ruanda 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 2.848
Città #
Singapore 340
Chandler 210
Dublin 141
San Jose 97
Hong Kong 92
Dong Ket 75
Ashburn 69
San Mateo 51
Santa Clara 39
Altamura 37
Beijing 35
Boardman 32
Wilmington 32
Los Angeles 30
Medford 29
Moscow 29
Princeton 28
Des Moines 27
Lawrence 27
Lauterbourg 26
Perugia 24
Ann Arbor 22
Hanoi 21
Timisoara 18
Frankfurt am Main 17
Andover 14
Munich 14
New York 13
Tokyo 12
Dallas 11
The Dalles 11
Falls Church 10
Ho Chi Minh City 10
Saint Petersburg 10
Orem 9
São Paulo 9
Baghdad 7
Brooklyn 7
Norwalk 7
Nuremberg 7
Turku 7
Atlanta 6
Helsinki 6
Lappeenranta 6
Seoul 6
Stockholm 6
Toronto 6
Warsaw 6
Brussels 5
Bucharest 5
Chennai 5
Columbus 5
Denver 5
San Francisco 5
San Paolo di Civitate 5
Amsterdam 4
Chicago 4
Falkenstein 4
London 4
Poplar 4
Querétaro 4
Redwood City 4
Brasília 3
Buenos Aires 3
Campinas 3
Charlotte 3
Houston 3
Hải Dương 3
Istanbul 3
Johannesburg 3
Lombard 3
Paris 3
Secaucus 3
Tashkent 3
Wroclaw 3
Zhengzhou 3
Acalanes Ridge 2
Algiers 2
Amman 2
Asunción 2
Augusta 2
Buffalo 2
Casablanca 2
Cincinnati 2
Dayton 2
Delhi 2
Den Haag 2
Dhaka 2
Donostia / San Sebastian 2
Duque de Caxias 2
Fairfield 2
Fremont 2
Haiphong 2
Izmir 2
Jakarta 2
Jeddah 2
Karbala 2
Kathmandu 2
Kingston 2
Madrid 2
Totale 1.901
Nome #
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 136
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 129
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 125
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 125
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 124
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 120
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 112
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 110
Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers 106
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers 104
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 100
Biomarker-based signature of alzheimer’s disease in pre-MCI individuals 99
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 98
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 95
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry 92
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 91
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 89
Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms 89
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 88
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 88
Parkinson's and Lewy body dementia CSF biomarkers 87
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases 87
Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity 86
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 84
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study 79
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study 78
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 77
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders 74
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: A 'European ADNI study' 69
Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer's Disease 44
null 13
Machine learning in Alzheimer’s disease genetics 12
Transferability of European-derived Alzheimer’s disease polygenic risk scores across multiancestry populations 7
Totale 2.917
Categoria #
all - tutte 13.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022181 0 0 0 2 11 8 7 58 8 17 35 35
2022/2023596 33 110 7 71 40 75 0 30 202 2 19 7
2023/2024169 14 21 9 7 2 0 42 3 4 15 31 21
2024/2025455 4 39 11 28 46 46 10 34 92 31 74 40
2025/20261.130 59 94 42 101 185 123 193 67 99 91 58 18
2026/202785 19 33 33 0 0 0 0 0 0 0 0 0
Totale 2.917